SEC Form 4 · accession 0001209191-17-049215
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lee R. McCracken
Director
Period of report
Aug 15, 2017
Accepted (ET)
Aug 16, 2017 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.27 | Aug 15, 2017 | A | 6,000 | A | — | Aug 14, 2027 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1The shares will vest monthly in equal installments over a one-year period such that the stock option is fully vested on August 15, 2018.